International Journal of Gynecological Cancer

Papers
(The H4-Index of International Journal of Gynecological Cancer is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study297
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy139
Growing teratoma syndrome133
Inguinofemoral lymphadenectomy technique in 10 steps102
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization99
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer72
Three-dimensional image of uterine transposition67
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico65
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery64
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer56
Management of stage III and IVa uterine cancer55
Well-differentiated papillary mesothelial tumor of the peritoneum52
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer46
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins44
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma44
Surgical technique and surgeon volume: the pursuit of data-driven outcomes43
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry42
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’42
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer42
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades42
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)42
Authors’ response to: “Methodological concerns regarding AGO score validation in low-grade ovarian cancers”41
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy40
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report39
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma39
Evaluating the use of machine learning in endometrial cancer: a systematic review38
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets37
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care36
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies34
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation34
Response to the letter regarding the article "Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA"34
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco34
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study33
0.04192590713501